Webster, TX, United States of America

Andrew Po Kwan Tang


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2007-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Andrew Po Kwan Tang

Introduction

Andrew Po Kwan Tang is a notable inventor based in Webster, Texas. He has made significant contributions to the field of pharmaceutical compositions, particularly in the development of methods for therapy using thrombin peptide derivatives. With a total of two patents to his name, Tang's work has the potential to impact medical treatments significantly.

Latest Patents

Tang's latest patents focus on pharmaceutical compositions that include thrombin peptide derivatives. These compositions are designed to incorporate a chelating agent and/or a pharmaceutically acceptable thiol-containing compound. Additionally, the compositions may contain an antioxidant. The methods outlined in these patents involve activating the non-proteolytically activated thrombin receptor in subjects requiring treatment. This is achieved by administering an effective amount of the thrombin peptide derivative contained in the pharmaceutical composition.

Career Highlights

Andrew Po Kwan Tang is associated with Orthologic Corporation, where he continues to innovate in the pharmaceutical field. His work is characterized by a commitment to advancing therapeutic methods that can enhance patient care and treatment outcomes.

Collaborations

Some of Tang's notable coworkers include David W. Hobson and Roger S. Crowther. Their collaboration likely contributes to the innovative environment at Orthologic Corporation.

Conclusion

Andrew Po Kwan Tang's contributions to pharmaceutical innovations demonstrate his dedication to improving medical therapies. His patents reflect a deep understanding of complex biochemical interactions and a commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…